Effect of Cancer Stage on Adverse Kidney Outcomes in Patients Receiving Immune Checkpoint Inhibitors for Melanoma.

Wang, Qiyu; Strohbehn, Ian A; Zhao, Sophia; Seethapathy, Harish; Strohbehn, Samuel D; Hanna, Paul; Lee, Meghan; Fadden, Riley; Sullivan, Ryan J; Boland, Genevieve M; Reynolds, Kerry L; Sise, Meghan E

Wang, Qiyu; Strohbehn, Ian A; Zhao, Sophia; Seethapathy, Harish; Strohbehn, Samuel D; Hanna, Paul; Lee, Meghan; Fadden, Riley; Sullivan, Ryan J; Boland, Genevieve M; Reynolds, Kerry L; Sise, Meghan E.

Afiliação

Wang Q; Department of Medicine, Division of Nephrology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Strohbehn IA; Department of Medicine, Division of Nephrology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Zhao S; Department of Medicine, Division of Nephrology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Seethapathy H; Department of Medicine, Division of Nephrology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Strohbehn SD; Department of Medicine, Division of Nephrology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Hanna P; Department of Medicine, Division of Nephrology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Lee M; Department of Medicine, Division of Nephrology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Fadden R; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Sullivan RJ; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Boland GM; Division of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.
Reynolds KL; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Sise ME; Department of Medicine, Division of Nephrology, Massachusetts General Hospital, Boston, Massachusetts, USA.

Kidney Int Rep ; 7(11): 2517-2521, 2022 Nov.

Article em En | MEDLINE | ID: mdl-36531890

Palavras-chave

anticytotoxic T-lymphocyte-associated protein 4; antiprogrammed cell death protein 1; chronic kidney disease; immune checkpoint inhibitor-associated AKI; immune-related adverse events; melanoma

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article